ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 66 filers reported holding ACUMEN PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,303 | -52.3% | 39,832 | -44.7% | 0.00% | – |
| Q2 2023 | $346,291 | +279.4% | 71,994 | +220.2% | 0.00% | – |
| Q1 2023 | $91,273 | -68.7% | 22,481 | -58.4% | 0.00% | – |
| Q4 2022 | $291,600 | -80.2% | 54,000 | -63.2% | 0.00% | – |
| Q3 2022 | $1,470,000 | +481.0% | 146,600 | +172.7% | 0.00% | – |
| Q2 2022 | $253,000 | -62.6% | 53,749 | -69.0% | 0.00% | – |
| Q1 2022 | $677,000 | +34.3% | 173,247 | +132.5% | 0.00% | – |
| Q4 2021 | $504,000 | -13.8% | 74,523 | +89.4% | 0.00% | – |
| Q3 2021 | $585,000 | – | 39,346 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $14,180,861 | 4.20% |
| Knollwood Investment Advisory, LLC | 1,628,510 | $6,758,317 | 3.16% |
| Altium Capital Management LP | 650,000 | $2,697,500 | 1.41% |
| RA Capital Management | 14,932,063 | $61,968,061 | 1.22% |
| GREAT POINT PARTNERS LLC | 1,074,101 | $4,457,519 | 0.81% |
| Boxer Capital, LLC | 2,206,983 | $9,158,979 | 0.49% |
| Deep Track Capital, LP | 2,513,044 | $10,429,133 | 0.40% |
| Parkman Healthcare Partners LLC | 499,814 | $2,074,228 | 0.38% |
| Rock Springs Capital Management LP | 2,812,579 | $11,672,203 | 0.31% |
| Ghost Tree Capital, LLC | 150,000 | $622,500 | 0.20% |